A cell line for high-yield production of E1-deleted adenovirus vectors without the emergence of replication-competent virus

被引:28
作者
Gao, GP
Engdahl, RK
Wilson, JM
机构
[1] Wistar Inst, Philadelphia, PA 19104 USA
[2] Univ Penn, Inst Human Gene Therapy, Philadelphia, PA 19104 USA
[3] Univ Penn, Dept Mol & Cellular Engn, Philadelphia, PA 19104 USA
关键词
D O I
10.1089/10430340050016283
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Production of E1-deleted adenovirus vectors for gene therapy has been plagued by the emergence of replication-competent adenovirus. A number of investigators have minimized homologous sequences between the vector and transfected E1 DNA in an attempt to avoid replication-competent adenovirus, We describe a HeLa-based cell line called GH329 that stably expresses the E1 locus from a promoter derived from the phosphoglycerate kinase gene. Overlap sequences with a standard E1-deleted vector that retains a full pIX transcriptional unit have been eliminated at the 5' end and minimized at the 3' end. The GH329 cell line plaques and produces E1-deleted adenovirus as well as 293 cells. Replication-competent virus has emerged after 5 passages of vector on 293 cells but was not detected after 20 passages on GH329 cells.
引用
收藏
页码:213 / 219
页数:7
相关论文
共 18 条
[11]   TRANSCOMPLEMENTATION OF E1-DELETED ADENOVIRUS - A NEW VECTOR TO REDUCE THE POSSIBILITY OF CODISSEMINATION OF WILD-TYPE AND RECOMBINANT ADENOVIRUSES [J].
IMLER, JL ;
BOUT, A ;
DREYER, D ;
DIETERLE, A ;
SCHULTZ, H ;
VALERIO, D ;
MEHTALI, M ;
PAVIRANI, A .
HUMAN GENE THERAPY, 1995, 6 (06) :711-721
[12]   Development of cell lines capable of complementing E1, E4, and protein IX defective adenovirus type 5 mutants [J].
Krougliak, V ;
Graham, FL .
HUMAN GENE THERAPY, 1995, 6 (12) :1575-1586
[13]   EMERGENCE OF EARLY REGION-1-CONTAINING REPLICATION-COMPETENT ADENOVIRUS IN STOCKS OF REPLICATION-DEFECTIVE ADENOVIRUS RECOMBINANTS (DELTA-E1 PLUS DELTA-E3) DURING MULTIPLE PASSAGES IN 293-CELLS [J].
LOCHMULLER, H ;
JANI, A ;
HUARD, J ;
PRESCOTT, S ;
SIMONEAU, M ;
MASSIE, B ;
KARPATI, G ;
ACSADI, G .
HUMAN GENE THERAPY, 1994, 5 (12) :1485-1491
[14]   PROMOTER-REGULATORY REGION OF THE MAJOR IMMEDIATE EARLY GENE OF HUMAN CYTOMEGALOVIRUS [J].
THOMSEN, DR ;
STENBERG, RM ;
GOINS, WF ;
STINSKI, MF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (03) :659-663
[15]   GENE-THERAPY OF CYSTIC-FIBROSIS LUNG-DISEASE USING E1 DELETED ADENOVIRUSES - A PHASE-I TRIAL [J].
WILSON, JM ;
ENGELHARDT, JF ;
GROSSMAN, M ;
SIMON, RH ;
YANG, YP .
HUMAN GENE THERAPY, 1994, 5 (04) :501-519
[16]   CELLULAR-IMMUNITY TO VIRAL-ANTIGENS LIMITS E1-DELETED ADENOVIRUSES FOR GENE-THERAPY [J].
YANG, YP ;
NUNES, FA ;
BERENCSI, K ;
FURTH, EE ;
GONCZOL, E ;
WILSON, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (10) :4407-4411
[17]   Development of a complementing cell line and a system for construction of adenovirus vectors with E1 and E2a deleted [J].
Zhou, HS ;
ONeal, W ;
Morral, N ;
Beaudet, AL .
JOURNAL OF VIROLOGY, 1996, 70 (10) :7030-7038
[18]   Characterization of replication-competent adenovirus isolates from large-scale production of a recombinant adenoviral vector [J].
Zhu, JD ;
Grace, M ;
Casale, J ;
Chang, ATI ;
Musco, ML ;
Bordens, R ;
Greenberg, R ;
Schaefer, E ;
Indelicato, SR .
HUMAN GENE THERAPY, 1999, 10 (01) :113-121